Pancreatic Serotonin-Producing Neuroendocrine Tumor

Pancreatic Serotonin-Producing Neuroendocrine Tumor — Trials · CancerIndex

Clinical trials

Registered studies

4 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 1–4 of 4 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03375320	Testing Cabozantinib in Patients With Advanced Pancreatic Neuroendocrine and Carcinoid Tumors	active not recruiting	Phase 3	298	National Cancer Institute (NCI)NIH	1	Sep 22, 2026	clinicaltrials
NCT07087054	Carcinoid Syndrome Efficacy Study Featuring an Oral Daily Paltusotine Regimen(CAREFNDR)	recruiting	Phase 3	141	Crinetics Pharmaceuticals Inc.INDUSTRY	14	Sep 15, 2026	clinicaltrials
NCT05361668	Study to Evaluate the Safety, PK, and Dose Response of Paltusotine in Subjects With Carcinoid Syndrome	completed	Phase 2	36	Crinetics Pharmaceuticals Inc.INDUSTRY	7	Mar 19, 2026	clinicaltrials
NCT04907643

Data updated 4 days agoSource updated Sep 22, 2026source: clinicaltrials